A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 13
Comprehensive Pages
- 31
States Represented
- 111
Survey Participants
- 12
COVID-19 Impact Topics Covered
Latest Industry News & Trends
9/25/2020
BreakingCataractIOLOphthalmicSurgical
Rayner to Launch RayOne EMV Enhanced Monofocal IOL in Europe
British IOL maker Rayner has announced the upcoming European launch of its RayOne EMV preloaded non-diffractive IOL, optimized for monovision. Rayner said the RayOne EMV extends a patient’s range o...
9/25/2020
BreakingFundingGlaucomaOphthalmicRetina
Graybug Vision Raises $90 Million in Upsized IPO
Graybug Vision reported Sept. 24 that it raised $90 million in an upsized initial public offering of 5,625,000 shares at a price of $16. The Redwood City, California, company was set to begin tradi...
9/25/2020
BreakingDealsOphthalmicPharma
Bausch Health Acquires Option to Purchase All Ophthalmology Assets of Allegro in Deal Worth Potential $50 Million
Bausch Health announced Sept. 21 that ithad agreed to acquire an option to purchase all ophthalmology assets of Allegro Ophthalmics, including global rights for risuteganib (Luminate). The option p...
9/25/2020
BreakingOphthalmicPharmaRegulation
US Ophthalmic Groups Ask FDA to Keep Moxifloxacin on 503B Bulk List
.jpg)
Major ophthalmic groups sent a letter to the US FDA on Sept. 11 asking that the agency keep moxifloxacin on the list of bulk products that 503B outsourcing facilitiesmay use in compounded products....
9/25/2020
BreakingLaserOphthalmic
Quantel Medical Adds Mosar High-Def Imaging to Easyret Yellow Laser
Quantel Medical announced Sept. 4 that it had added the Mosar optional imaging system to its Easyret yellow retinal laser. Mosar is CE marked, FDA approved, and available for sale, the French laser...
9/25/2020
BreakingDry EyeGlaucomaLaserMeetingOphthalmic
Lumenis Takes Mobile Trade Show Booth on US Tour
The COVID-19 pandemic has left companies struggling to get their products in front of doctors, as in-person trade shows have been canceled across the globe for months, with no end in sight. Lumenis...
9/25/2020
BreakingClinical TrialOphthalmicPharma
Ocumension Gets Green Light in China to Begin Trial of Nicox’ Zerviate
Nicox, of France, and China’s Ocumension Therapeutics announced Sept. 22 that Ocumension had received approval from China’s National Medical Products Administration to carry out a Phase III clinica...
9/25/2020
BreakingClinical TrialGlaucomaOphthalmicPharma
Aerpio Completes Enrollment in 28-Day Phase II Trial of Razuprotafib for Glaucoma
Aerpio Pharmaceuticals announced Sept. 15 that it had completed patient enrollment in a Phase II trial in patients with elevated intraocular pressure (IOP) associated with open angle glaucoma (OAG)...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.